Expertise in
4
conditions

Cezary Kepka

Warsaw, MZ, PL 
Expertise in
4
conditions
Warsaw, MZ, PL 

Overview

Cezary Kepka practices practicing medicine in Warsaw, Poland.

Kepka is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Coronary Heart Disease, Atherosclerosis, Congenital Coronary Artery Malformation, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

They are actively involved in clinical research, co-authoring 141 peer reviewed articles and participating in 2 clinical trials.

Locations

Warsaw, MZ, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities. A Multicentre Post-marketing Trial of a Class 2a Medical Device, Cardiolens FFR-CT Pro - Software for Non-invasive Determination of Haemodynamic Parameters in Coronary Arteries.
Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities. A Multicentre Post-marketing Trial of a Class 2a Medical Device, Cardiolens FFR-CT Pro - Software for Non-invasive Determination of Haemodynamic Parameters in Coronary Arteries.
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Procedure, Device
Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).
Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).
Enrollment Status: Completed
Publish Date: September 17, 2019
View 1 Less Clinical Trial

141 Total Publications

Inflammation on the move: A rare cause of partial coronary stent displacement.
Inflammation on the move: A rare cause of partial coronary stent displacement.
Journal: Kardiologia polska
Published: August 07, 2026

Frequently Asked Questions about Cezary Kepka

Is Cezary Kepka a top-rated expert for Coronary Heart Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Cezary Kepka is classified as an Elite expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Cezary Kepka participate in research or clinical trials?

Yes. Cezary Kepka has published 141 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Cezary Kepka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kepka's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile